- Home
- ACNB vs FATE Comparison
ACNB vs FATE Comparison
Compare ACNB & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- FATE
- Stock Information
- Founded
- ACNB 1857
- FATE 2007
- Country
- ACNB United States
- FATE United States
- Employees
- ACNB N/A
- FATE N/A
- Industry
- ACNB Major Banks
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACNB Finance
- FATE Health Care
- Exchange
- ACNB Nasdaq
- FATE Nasdaq
- Market Cap
- ACNB 401.0M
- FATE 406.5M
- IPO Year
- ACNB N/A
- FATE 2013
- Fundamental
- Price
- ACNB $47.62
- FATE $2.07
- Analyst Decision
- ACNB Buy
- FATE Hold
- Analyst Count
- ACNB 3
- FATE 10
- Target Price
- ACNB $45.00
- FATE $6.75
- AVG Volume (30 Days)
- ACNB 18.9K
- FATE 3.0M
- Earning Date
- ACNB 10-24-2024
- FATE 11-12-2024
- Dividend Yield
- ACNB 2.71%
- FATE N/A
- EPS Growth
- ACNB N/A
- FATE N/A
- EPS
- ACNB 3.44
- FATE N/A
- Revenue
- ACNB $106,401,000.00
- FATE $13,447,000.00
- Revenue This Year
- ACNB N/A
- FATE N/A
- Revenue Next Year
- ACNB $20.49
- FATE N/A
- P/E Ratio
- ACNB $13.72
- FATE N/A
- Revenue Growth
- ACNB N/A
- FATE N/A
- 52 Week Low
- ACNB $30.24
- FATE $1.96
- 52 Week High
- ACNB $50.72
- FATE $8.83
- Technical
- Relative Strength Index (RSI)
- ACNB 59.10
- FATE 36.05
- Support Level
- ACNB $46.63
- FATE $1.96
- Resistance Level
- ACNB $49.01
- FATE $2.35
- Average True Range (ATR)
- ACNB 1.90
- FATE 0.34
- MACD
- ACNB 0.02
- FATE -0.01
- Stochastic Oscillator
- ACNB 68.01
- FATE 7.14
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.